<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Indigo carmine: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Indigo carmine: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Indigo carmine: Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="9088" href="/d/html/9088.html" rel="external">see "Indigo carmine: Drug information"</a> and <a class="drug drug_patient" data-topicid="140345" href="/d/html/140345.html" rel="external">see "Indigo carmine: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F20452405"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Bludigo;</li>
<li>Indigo Carmine [DSC]</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F990953"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Diagnostic Agent, Kidney Function</span></li></ul></div>
<div class="block dop drugH1Div" id="F7306226"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="ee21b0dc-5e6e-49fb-83e9-0dcd0812814c">Localizing ureteral orifices</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Localizing ureteral orifices:</b> Limited data available:</p>
<p style="text-indent:-2em;margin-left:4em;">Infants and Children: IV: &lt;5 mL; to avoid skin discoloration, doses less than the usual adolescent/adult dose of 5 mL necessary; has also been administered locally into the ureter(s) during cystoscopy procedure (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26285894','lexi-content-ref-29217322','lexi-content-ref-IndigoCarmine.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26285894','lexi-content-ref-29217322','lexi-content-ref-IndigoCarmine.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Adolescents: IV: Usual dose: 5 mL; patients who are small for age may need lower dose (&lt;5 mL) to prevent skin discoloration; has also been administered locally into the ureter(s) during cystoscopy procedure (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26285894','lexi-content-ref-29217322','lexi-content-ref-IndigoCarmine.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26285894','lexi-content-ref-29217322','lexi-content-ref-IndigoCarmine.1'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51113741"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block dohp drugH1Div" id="F51113742"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doa drugH1Div" id="F7306227"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="9088" href="/d/html/9088.html" rel="external">see "Indigo carmine: Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="ce9309d5-6d36-47de-9e8a-d3b97bfb2f2c">Localization of ureteral orifices</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Localization of ureteral orifices:</b>
<b>IV:</b> 5 mL.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990644"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Note:</b> eGFR may be estimated using the MDRD formula for dosage adjustment purposes.</p>
<p style="text-indent:-2em;margin-left:2em;">eGFR ≥30 mL/minute: No dosage adjustment necessary.</p>
<p style="text-indent:-2em;margin-left:2em;">eGFR &lt;30 mL/minute: Use not recommended (has not been studied).</p></div>
<div class="block doha drugH1Div" id="F50987844"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F243427"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Reported adverse reactions are for adults.</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Abdominal pain (3%), constipation (5%), nausea (3%), vomiting (3%)</p>
<p style="text-indent:-2em;margin-left:4em;">Genitourinary: Dysuria (2%)</p>
<p style="text-indent:-2em;margin-left:4em;">Hepatic: Increased serum alanine aminotransferase (3%)</p>
<p style="text-indent:-2em;margin-left:4em;">Miscellaneous: Fever (3%)</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing:</p>
<p style="text-indent:-2em;margin-left:4em;">Cardiovascular: Asystole, bradycardia (Satoh 2001; Wu 1969), cardiac arrhythmia, hypotension (including severe hypotension) (Shir 1993), increased blood pressure (Wu 1969), second-degree atrioventricular block (Hobai 2008), tachycardia</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Anaphylaxis (Nandate 2016), nonimmune anaphylaxis (Nandate 2016)</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Skin discoloration at injection site</p></div>
<div class="block coi drugH1Div" id="F243438"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to indigotindisulfonate sodium or any component of the formulation.</p></div>
<div class="block war drugH1Div" id="F243425"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Cardiovascular: Severe or life-threatening cardiovascular reactions, including cardiac arrest, arrhythmia, asystole, second degree atrioventricular block, hypotension, hypertension, bradycardia, and tachycardia, have been reported generally within 60 minutes following administration. May also cause vasoconstriction by interference with vasodilation mediated by nitric oxide dependent mechanisms and by direct vasoconstriction.</p>
<p style="text-indent:-2em;margin-left:4em;">• Hypersensitivity reactions: Serious anaphylactic reactions with hypotension, dyspnea, bronchospasm, urticaria, or erythema have been reported<i>; </i>emergency equipment and trained personnel must be available.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Oximetry measurement interference: May interfere with light absorption leading to a transient, artifactual reduction in SpO<sub>2</sub>.</p>
<p style="text-indent:-2em;margin-left:4em;">• Urine discoloration: May cause a temporary blue discoloration of urine; usually resolves within 48 hours.</p></div>
<div class="block foc drugH1Div" id="F243434"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Injection: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Indigo Carmine: 8 mg/mL (5 mL [DSC])</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Bludigo: 8 mg/mL (5 mL)</p></div>
<div class="block geq drugH1Div" id="F20452404"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F57229571"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Bludigo Intravenous)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">8 mg/mL (per mL): $96.00</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block admp drugH1Div" id="F52614087"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Parenteral:</p>
<p style="text-indent:-2em;margin-left:2em;">IV (preferred): Administer undiluted over 1 minute. Withdraw contents using a ≤5-micron filter needle/straw only.</p>
<p style="text-indent:-2em;margin-left:2em;">Local: Has been administered into ureter(s) as part of cystoscopy procedure in pediatric patients (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26285894','lexi-content-ref-29217322']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26285894','lexi-content-ref-29217322'])">Ref</a></span>).</p></div>
<div class="block adm drugH1Div" id="F7306228"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>IV:</b> Administer undiluted over 1 minute; withdraw ampule contents through a ≤5-micron filter straw/filter needle.</p></div>
<div class="block sts drugH1Div" id="F7306220"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:0em;display:inline">Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Store in original carton to protect from light. Do not refrigerate or freeze. Use ampule immediately after opening; discard unused portion.</p></div>
<div class="block usep drugH1Div" id="F53569710"><span class="drugH1">Use</span>
<p style="text-indent:0em;display:inline">Use as a visualization aid in the cystoscopic assessment of the integrity of the ureters following urological and gynecological open, robotic, or endoscopic surgical procedures (Bludigo: FDA approved in adults).</p></div>
<div class="block pri drugH1Div" id="F7306211"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Animal reproduction studies have not been conducted with IV indigotindisulfonate sodium.</p>
<p style="text-indent:0em;margin-top:2em;">Outcome data following first trimester exposure are limited. Administration of indigotindisulfonate sodium into the amniotic fluid has been used to diagnose prelabor rupture of membranes (ACOG 2020; Adekola 2016; Ireland 2017).</p></div>
<div class="block mopp drugH1Div" id="F57460426"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Blood pressure, heart rate/rhythm.</p></div>
<div class="block phk drugH1Div" id="F243437"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Onset of action: Blue color is detectable at the ureteral orifices within 4 to 9 minutes following injection.</p>
<p style="text-indent:-2em;margin-left:2em;">Distribution: V<sub>d</sub>: 10.7 L.</p>
<p style="text-indent:-2em;margin-left:2em;">Protein binding: ~90%.</p>
<p style="text-indent:-2em;margin-left:2em;">Half-life elimination: IV injection: 12 minutes.</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Urine (16%, as unchanged drug); feces (&lt;2%).</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F58200980"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Carmyne</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Indigocarmin</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Carmyne</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Indigocarmin</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Indigocarmine daiichi</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Carmin</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Indigokarmijn serb</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Indigocarmin</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-25714481">
<a name="25714481"></a>Adekola H, Gill N, Sakr S, et al. Outcomes following intra-amniotic instillation with indigo carmine to diagnose prelabor rupture of membranes in singleton pregnancies: a single center experience. <i>J Matern Fetal Neonatal Med</i>. 2016;29(4):544-549. doi:10.3109/14767058.2015.1015982<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/indigo-carmine-pediatric-drug-information/abstract-text/25714481/pubmed" id="25714481" target="_blank">25714481</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32080050">
<a name="32080050"></a>American College of Obstetricians and Gynecologists (ACOG). Prelabor rupture of membranes: ACOG practice bulletin, number 217. <i>Obstet Gynecol</i>. 2020;135(3):e80-e97. doi:10.1097/AOG.0000000000003700<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/indigo-carmine-pediatric-drug-information/abstract-text/32080050/pubmed" id="32080050" target="_blank">32080050</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Bludigo (indigotindisulfonate sodium) [prescribing information]. Collegeville, Pennsylvania: Provepharm Inc; July 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18835972">
<a name="18835972"></a>Hobai IA. Atrioventricular block induced by indigo carmine. <i>Can J Anaesth</i>. 2008;55(10):717-718. doi:10.1007/BF03017750<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/indigo-carmine-pediatric-drug-information/abstract-text/18835972/pubmed" id="18835972" target="_blank">18835972</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-IndigoCarmine.1">
<a name="IndigoCarmine.1"></a>Indigo Carmine (indigotindisulfonate sodium) [prescribing information]. Shirley, NY: American Regent, Inc.; February 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28486367">
<a name="28486367"></a>Ireland KE, Rodriguez EI, Acosta OM, Ramsey PS. Intra-amniotic dye alternatives for the diagnosis of preterm prelabor rupture of membranes. <i>Obstet Gynecol</i>. 2017;129(6):1040-1045. doi:10.1097/AOG.0000000000002056<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/indigo-carmine-pediatric-drug-information/abstract-text/28486367/pubmed" id="28486367" target="_blank">28486367</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27610263">
<a name="27610263"></a>Nandate K, Voelzke BB. Severe hypotension, hypoxia, and subcutaneous erythema induced by indigo carmine administration during open prostatectomy. <i>Case Rep Urol</i>. 2016;2016:5237387. doi:10.1155/2016/5237387<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/indigo-carmine-pediatric-drug-information/abstract-text/27610263/pubmed" id="27610263" target="_blank">27610263</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29217322">
<a name="29217322"></a>Okawada M, Murakami H, Tanaka N, et al. Incidence of ureterovesical obstruction and Cohen antireflux surgery after Deflux treatment for vesicoureteric reflux. <i>J Pediatr Surg</i>. 2018;53(2):310-312. doi:10.1016/j.jpedsurg.2017.11.027<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/indigo-carmine-pediatric-drug-information/abstract-text/29217322/pubmed" id="29217322" target="_blank">29217322</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26285894">
<a name="26285894"></a>Okawada M, Shibuya S, Doi T, et al. Ureteric patency after Deflux injection for the treatment of vesicoureteric reflux in children confirmed by a novel epidural catheter-assisted endoscopic technique. <i>Pediatr Surg Int</i>. 2015;31(10):977-982. doi:10.1007/s00383-015-3778-9<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/indigo-carmine-pediatric-drug-information/abstract-text/26285894/pubmed" id="26285894" target="_blank">26285894</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11133645">
<a name="11133645"></a>Satoh K, Sakamoto N, Shinohe Y, Satoh M, Joh S. Indigo carmine-induced bradycardia in a patient during general anesthesia. <i>Anesth Analg</i>. 2001;92(1):276-277. doi:10.1097/00000539-200101000-00056<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/indigo-carmine-pediatric-drug-information/abstract-text/11133645/pubmed" id="11133645" target="_blank">11133645</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8342846">
<a name="8342846"></a>Shir Y, Raja SN. Indigo carmine-induced severe hypotension in patients undergoing radical prostatectomy. <i>Anesthesiology</i>. 1993;79(2):378-381. doi:10.1097/00000542-199308000-00024<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/indigo-carmine-pediatric-drug-information/abstract-text/8342846/pubmed" id="8342846" target="_blank">8342846</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-5783815">
<a name="5783815"></a>Wu CC, Johnson AJ. The vasopressor effect of indigo carmine. <i>Henry Ford Hosp Med J</i>. 1969;17(2):131-137.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/indigo-carmine-pediatric-drug-information/abstract-text/5783815/pubmed" id="5783815" target="_blank">5783815</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 115291 Version 48.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
